• Takeda Pharmaceutical average return on equity for 2023 was 3.82, a 33.57% decline from 2022.
• Takeda Pharmaceutical average return on equity for 2022 was 2.86, a 69.7% increase from 2021.
• Takeda Pharmaceutical average return on equity for 2021 was 9.44, a 249.63% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.